Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Chopin

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Tumori|March 23, 2019
Tubular and mucinous breast cancer: results of a cohort of 917 patientsPauline Roux, Sophie Knight, Monique Cohen, et al.
Cancers|January 13, 2021
Molecular Characterization of Ovarian Yolk Sac Tumor (OYST)Khalil Hodroj, Aleksandra Stevovic, Valery Attignon, et al.
JCI Insight|September 22, 2021
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancerClaudia Winkler, Matthew King, Julie Berthe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2022
Serodolin, a β-arrestin-biased ligand of 5-HT<sub>7</sub> receptor, attenuates pain-related behaviorsChayma El Khamlichi, Flora Reverchon, Nadège Hervouet-Coste, et al.
Cancer Research|March 22, 2018
Autocrine Adenosine Regulates Tumor Polyfunctional CD73<sup>+</sup>CD4<sup>+</sup> Effector T Cells Devoid of Immune CheckpointsNicolas Gourdin, Marion Bossennec, Céline Rodriguez, et al.
European Journal of Medicinal Chemistry|September 19, 2022
Evaluation of ferrocenyl-containing γ-hydroxy-γ-lactam-derived tetramates as potential antiplasmodialsNicolas Chopin, Julien Bosson, Shinya Iikawa, et al.
Breast (Edinburgh, Scotland)|August 2, 2016
Breast cancer in young women: Pathologic features and molecular phenotypeLaura Sabiani, Gilles Houvenaeghel, Mellie Heinemann, et al.
Bulletin Du Cancer|September 10, 2025
[Understanding biology to identify new therapeutic targets beyond chemotherapy in ovarian granulosa cell tumors]Sil Endale Ahanda, Alexandra Lainé, Brunhilde Hanvic, et al.
Bulletin Du Cancer|March 3, 2020
Detailed overview on rare malignant ovarian tumorsStefanie Aust, Lauriane Eberst, Olivier Tredan, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Tumori|March 23, 2019
Tubular and mucinous breast cancer: results of a cohort of 917 patientsPauline Roux, Sophie Knight, Monique Cohen, et al.
Cancers|January 13, 2021
Molecular Characterization of Ovarian Yolk Sac Tumor (OYST)Khalil Hodroj, Aleksandra Stevovic, Valery Attignon, et al.
JCI Insight|September 22, 2021
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancerClaudia Winkler, Matthew King, Julie Berthe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2022
Serodolin, a β-arrestin-biased ligand of 5-HT<sub>7</sub> receptor, attenuates pain-related behaviorsChayma El Khamlichi, Flora Reverchon, Nadège Hervouet-Coste, et al.
Cancer Research|March 22, 2018
Autocrine Adenosine Regulates Tumor Polyfunctional CD73<sup>+</sup>CD4<sup>+</sup> Effector T Cells Devoid of Immune CheckpointsNicolas Gourdin, Marion Bossennec, Céline Rodriguez, et al.
European Journal of Medicinal Chemistry|September 19, 2022
Evaluation of ferrocenyl-containing γ-hydroxy-γ-lactam-derived tetramates as potential antiplasmodialsNicolas Chopin, Julien Bosson, Shinya Iikawa, et al.
Breast (Edinburgh, Scotland)|August 2, 2016
Breast cancer in young women: Pathologic features and molecular phenotypeLaura Sabiani, Gilles Houvenaeghel, Mellie Heinemann, et al.
Bulletin Du Cancer|September 10, 2025
[Understanding biology to identify new therapeutic targets beyond chemotherapy in ovarian granulosa cell tumors]Sil Endale Ahanda, Alexandra Lainé, Brunhilde Hanvic, et al.
Bulletin Du Cancer|March 3, 2020
Detailed overview on rare malignant ovarian tumorsStefanie Aust, Lauriane Eberst, Olivier Tredan, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
Pageof 7